Skip to main content
. 2019 Jun 25;11(3):83–94.

Table 2.

List of ongoing clinical trials comparing TIVA to volatile aneasthesia

Trial identifier Cancer type Estimated enrollment Study arms Outcomes Trial status and estimated completion date
NCT03193710 Colorectal cancer 260 Propofol vs Sevoflurane Cancer free survival, Recurrence, metastasis up to 5 years Recruiting, October 2023
NCT03034096 All cancer surgery 2000 Propofol vs volatiles Mortality, recurrence free survival at least 2 years Recruiting, December 2020
NCT02839668 Breast cancer 120 Propofol vs sevoflurane; +/- Lidocaine Survival up to 1 year Ongoing, December 2018
NCT02786329 Colorectal cancer 450 Propofol vs sevoflurane Recurrence up to 5 years Recruiting, December 2021
NCT02756312 Malignant Glioma 500 Propofol vs volatiles Progression free survival up to 1 year Ongoing, December 2018
NCT01975064 Breast, colorectal cancer 8000 Propofol vs sevoflurane Survival after 5 years Recruiting, December 2022
NCT02660411 All cancer surgery 1200 Propofol vs sevoflurane Survival and recurrence free survival up to 3 years Ongoing, December 2020